Literature DB >> 18804345

Geographic variation and sociodemographic characteristics of psychotic disorders in Finland.

Jonna Perälä1, Samuli I Saarni, Aini Ostamo, Sami Pirkola, Jari Haukka, Tommi Härkänen, Seppo Koskinen, Jouko Lönnqvist, Jaana Suvisaari.   

Abstract

BACKGROUND: Geographical variation and sociodemographic characteristics may differ in affective and nonaffective psychotic disorders. We examined the geographical variation in the lifetime prevalence of psychotic disorders in a comprehensive general population study.
METHOD: A nationally representative sample of 8028 Finns aged 30 or over was screened for psychotic and bipolar I disorders and interviewed with the Structured Clinical Interview for DSM-IV. Best-estimate DSM-IV diagnoses were formed by combining interview and case note data. Nationwide health care register data were used for the nonrespondents. Associations with sociodemographic features, place of birth and residence in urban or rural areas and in five regions, and migration between the regions were examined.
RESULTS: Schizophrenia and other nonaffective psychoses, but not affective psychoses, showed prominent regional variation, with highest odds found for schizophrenia among those born in the North (OR 7.72 95%CI 2.48-24.04) and the East (OR 3.99 95%CI 1.22-13.11). The risk of any psychotic disorder was lower for those born in urban areas (OR 0.73 95%CI 0.54-0.98), but no associations were found for separate diagnostic groups. Region of birth was the strongest determinant of geographical variation when both place of birth and residence were accounted for. Selective migration was not found. Education and income were higher and being employed more common in subjects with affective psychosis than in subjects with other psychotic disorders.
CONCLUSIONS: Large area variation is more important than urban-rural disparity in psychotic disorders in Finland. Affective psychoses were different from nonaffective psychoses in terms of both regional variation and sociodemographic features.

Entities:  

Mesh:

Year:  2008        PMID: 18804345     DOI: 10.1016/j.schres.2008.08.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  The Top3β way to untangle RNA.

Authors:  Alexi Nott; Li-Huei Tsai
Journal:  Nat Neurosci       Date:  2013-09       Impact factor: 24.884

2.  Social inequalities in mental health: results from the EU contribution to the World Mental Health Surveys Initiative.

Authors:  Alejandra Pinto-Meza; Maria Victoria Moneta; Jordi Alonso; Matthias C Angermeyer; Ronny Bruffaerts; José Miguel Caldas de Almeida; Giovanni de Girolamo; Ron de Graaf; Silvia Florescu; Viviane Kovess Masfety; Siobhan O'Neill; Svetlozar Vassilev; Josep Maria Haro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-18       Impact factor: 4.328

3.  Risk of schizophrenia and minority status: a comparison of the Swedish-speaking minority and the Finnish-speaking majority in Finland.

Authors:  Jaana Suvisaari; Mark Opler; Marja-Liisa Lindbohm; Markku Sallmén
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

4.  Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland.

Authors:  Sini Kerminen; Alicia R Martin; Jukka Koskela; Sanni E Ruotsalainen; Aki S Havulinna; Ida Surakka; Aarno Palotie; Markus Perola; Veikko Salomaa; Mark J Daly; Samuli Ripatti; Matti Pirinen
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

5.  Employment trajectories until midlife in schizophrenia and other psychoses: the Northern Finland Birth Cohort 1966.

Authors:  Tuomas Majuri; Anni-Emilia Alakokkare; Marianne Haapea; Tanja Nordström; Jouko Miettunen; Erika Jääskeläinen; Leena Ala-Mursula
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-07-07       Impact factor: 4.328

6.  Description of long-term polypharmacy among schizophrenia outpatients.

Authors:  Jaana T Suokas; Jaana M Suvisaari; Jari Haukka; Pasi Korhonen; Jari Tiihonen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-25       Impact factor: 4.328

7.  Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders.

Authors:  Georg Stoll; Olli P H Pietiläinen; Bastian Linder; Jaana Suvisaari; Cornelia Brosi; William Hennah; Virpi Leppä; Minna Torniainen; Samuli Ripatti; Sirpa Ala-Mello; Oliver Plöttner; Karola Rehnström; Annamari Tuulio-Henriksson; Teppo Varilo; Jonna Tallila; Kati Kristiansson; Matti Isohanni; Jaakko Kaprio; Johan G Eriksson; Olli T Raitakari; Terho Lehtimäki; Marjo-Riitta Jarvelin; Veikko Salomaa; Matthew Hurles; Hreinn Stefansson; Leena Peltonen; Patrick F Sullivan; Tiina Paunio; Jouko Lönnqvist; Mark J Daly; Utz Fischer; Nelson B Freimer; Aarno Palotie
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

Review 8.  Diabetes and Schizophrenia.

Authors:  Jaana Suvisaari; Jaakko Keinänen; Saana Eskelinen; Outi Mantere
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

9.  AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes.

Authors:  Marjaana A Peltola; Juha Kuja-Panula; Johanna Liuhanen; Vootele Võikar; Petteri Piepponen; Tero Hiekkalinna; Tomi Taira; Sari E Lauri; Jaana Suvisaari; Natalia Kulesskaya; Tiina Paunio; Heikki Rauvala
Journal:  Schizophr Bull       Date:  2015-08-03       Impact factor: 9.306

10.  Global estimates of service coverage for severe mental disorders: findings from the WHO Mental Health Atlas 2017.

Authors:  Kara Jaeschke; Fahmy Hanna; Suhailah Ali; Neerja Chowdhary; Tarun Dua; Fiona Charlson
Journal:  Glob Ment Health (Camb)       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.